TY - JOUR
T1 - Angiogenesis and vascular maturation in neuroendocrine tumors
AU - Yazdani, Samaneh
AU - Kasajima, Atsuko
AU - Tamaki, Kentaro
AU - Nakamura, Yasuhiro
AU - Fujishima, Fumiyoshi
AU - Ohtsuka, Hideo
AU - Motoi, Fuyuhiko
AU - Unno, Michiaki
AU - Watanabe, Mika
AU - Sato, Yasufumi
AU - Sasano, Hironobu
N1 - Funding Information:
Funding/Support: This work was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology and Mitsui Life Social Welfare Foundation.
PY - 2014/4
Y1 - 2014/4
N2 - Neuroendocrine tumors (NETs) are highly vascularized, but the process of proliferation and maturation of vascular structures during tumor development and progression has remained unknown. We examined the structural alterations of intratumoral blood vessels in human gastroenteropancreatic NET. Microvessel density was evaluated using the endothelial cell markers vasohibin-1 (VASH-1), CD31, and endoglin in 135 cases. Double immunohistochemistry staining was performed to localize endothelium and pericytes on the same vessels using the pericyte marker nestin. The ratio of Ki-67/CD31 was significantly correlated with that of VASH-1/CD31 positivity (P <.001), indicating that the ratio of VASH-1/CD31 also reflects the status of neovascularization in NET. This ratio was higher in NET than in its nonneoplastic counterpart (P =.10) and tended to increase according to World Health Organization (WHO) grade, although the differences were not statistically significant (P =.32). The ratio of VASH-1/nestin-positive vessels, representing the maturation of neovessels, was also significantly higher in NET than in its nonneoplastic counterparts (P =.003). Among WHO grades, the ratio increased from grade 1 to grade 2 (P =.36) and decreased in neuroendocrine carcinoma (P =.34). Our results demonstrated that VASH-1/CD31 can be an ideal immunohistochemical marker for characterizing neovascularization in NET. The VASH-1/CD31 content increased with WHO grade, and the vessels covered by pericytes decreased in higher grades. These structural changes in the vessels are considered to play an important role in inducing tumor-cell proliferation.
AB - Neuroendocrine tumors (NETs) are highly vascularized, but the process of proliferation and maturation of vascular structures during tumor development and progression has remained unknown. We examined the structural alterations of intratumoral blood vessels in human gastroenteropancreatic NET. Microvessel density was evaluated using the endothelial cell markers vasohibin-1 (VASH-1), CD31, and endoglin in 135 cases. Double immunohistochemistry staining was performed to localize endothelium and pericytes on the same vessels using the pericyte marker nestin. The ratio of Ki-67/CD31 was significantly correlated with that of VASH-1/CD31 positivity (P <.001), indicating that the ratio of VASH-1/CD31 also reflects the status of neovascularization in NET. This ratio was higher in NET than in its nonneoplastic counterpart (P =.10) and tended to increase according to World Health Organization (WHO) grade, although the differences were not statistically significant (P =.32). The ratio of VASH-1/nestin-positive vessels, representing the maturation of neovessels, was also significantly higher in NET than in its nonneoplastic counterparts (P =.003). Among WHO grades, the ratio increased from grade 1 to grade 2 (P =.36) and decreased in neuroendocrine carcinoma (P =.34). Our results demonstrated that VASH-1/CD31 can be an ideal immunohistochemical marker for characterizing neovascularization in NET. The VASH-1/CD31 content increased with WHO grade, and the vessels covered by pericytes decreased in higher grades. These structural changes in the vessels are considered to play an important role in inducing tumor-cell proliferation.
KW - Neovascularization
KW - Neuroendocrine tumor
KW - Pericyte
KW - Vasohibin-1
UR - http://www.scopus.com/inward/record.url?scp=84896518261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896518261&partnerID=8YFLogxK
U2 - 10.1016/j.humpath.2013.09.024
DO - 10.1016/j.humpath.2013.09.024
M3 - Article
C2 - 24656098
AN - SCOPUS:84896518261
SN - 0046-8177
VL - 45
SP - 866
EP - 874
JO - Human Pathology
JF - Human Pathology
IS - 4
ER -